Alle afleveringen
364 afleveringen, van nieuw naar oud
-
Life sciences leadership: the pharmaphorum podcast
14 november 2019 · 43 min
Episode 15 of the pharmaphorum podcast marked a return visit for leading life sciences industry authority Professor Brian
-
AstraZeneca and lung cancer: the pharmaphorum podcast
7 augustus 2019 · 22 min
This episode of the pharmaphorum podcast focuses on lung cancer, with AstraZeneca’s VP, Global Franchise Head, Tagrisso TDR
-
Lung cancer’s patient information gap: the pharmaphorum podcast
6 augustus 2019 · 26 min
For episode 13 of the pharmaphorum podcast I went to AstraZeneca’s London base to meet Paul Naish, who’s
-
The state of UK drug discovery: the pharmaphorum podcast
19 juli 2019 · 33 min
The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all on the agenda for episode 12 of the pharmaphorum podcast. Lees meer
On it I spoke with Chris Molloy, who’s CEO at the UK’s Medicines Discovery Catapult, about the Catapult’s State of the Discovery Nation publication, a joint report with the UK’s biotech trade body the BioIndustry Association.
-
Addressing global health challenges: the pharmaphorum podcast
19 juni 2019 · 59 min
For episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to record a special roundtable episode in Philadelphia with the International AIDS Vaccine Initiative (IAVI).
-
Gene therapy and market access: the pharmaphorum podcast
31 mei 2019 · 20 min
For episode 10 of the pharmaphorum podcast I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK. Lees meer
The Cambridge, Massachusetts-based company has gone from being a gene therapy start-up to having three potential blockbusters on its books, with a CAR-T cancer medicine and potential treatments for a type of sickle-cell disease and a rare and deadly genetic brain disease.
-
AMR research and Matoke Pharma: the pharmaphorum podcast
13 mei 2019 · 24 min
Re-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a crucial step on the UK biotech company’s plans to target antimicrobial resistance (AMR). Lees meer
In episode 9 of the pharmaphorum podcast Alan Westwood explains the research behind Matoke’s SurgihoneyRO, an antimicrobial wound gel that has a CE mark in Europe, and how the company is taking that product’s reactive oxygen (RO) component to develop novel pharmaceutical antimicrobials.
-
GSK and digital disruption: the pharmaphorum podcast
5 april 2019 · 29 min
Digital innovation and disruption in healthcare are the subject of this episode of the pharmaphorum podcast, for which I visited GlaxoSmithKline at their Stockley Park base to speak with Kai Gait, a senior global digital strategy director at the company. Lees meer
-
Ipsen on neurotoxin research: the pharmaphorum podcast
28 maart 2019 · 12 min
For episode 7 of the pharmaphorum podcast I spoke to Ipsen’s Philippe Picaut about neurotoxin research, with a particular focus on Botulinum neurotoxins.
-
Successful medical marketing teams: the pharmaphorum podcast
22 februari 2019 · 25 min
The pharmaphorum podcast’s first episode of 2019 features Professor Brian D Smith on what makes a modern, and successful, medical marketing team.
-
Biotech strategy and nanomedicine: the pharmaphorum podcast
21 december 2018 · 20 min
For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach. Lees meer
-
Commercialising orphan drugs: the pharmaphorum podcast
20 november 2018 · 18 min
In episode 4 of the podcast pharmaphorum talked to Dr Joe Wiley, CEO of UK-based biopharmaceutical company Amryt Pharma, about its strategy and work in the rare diseases and gene therapy space.
-
The future biosimilar landscape: the pharmaphorum podcast
16 oktober 2018 · 42 min
For episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet the head of the company’s UK specialty business Kavya Gopal.
-
Nimble consumer healthcare innovation: the pharmaphorum podcast
14 september 2018 · 32 min
In episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how he’s seen the consumer health sector develop.